Skip to content

Schrodinger

US · SDGR #2667 by market cap Listed 2020
22.93 -3.41 -12.95%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Company notice
    Schrodinger | 4: Statement of changes in beneficial ownership of securities-Officer Tran Yvonne
    SEC · 2026/11/11
  • Morgan Stanley Maintains Schrodinger(SDGR.US) With Hold Rating, Raises Target Price to $29
    Market Newswire · 2026/11/6
  • Rating change
    Schrodinger Price Target Raised to $21.00/Share From $19.00 by UBS
    Dow Jones · 2026/10/20
  • Company notice
    Schrodinger | 4: Statement of changes in beneficial ownership of securities-Officer Abel Robert Lorne
    SEC · 2026/11/13
  • UBS Maintains Schrodinger(SDGR.US) With Hold Rating, Raises Target Price to $30
    Market Newswire · 2026/11/6
  • BofA Securities Initiates Schrodinger(SDGR.US) With Buy Rating
    Market Newswire · 2026/11/11
  • Rating change
    Schrodinger Price Target Raised to $31.00/Share From $20.00 by TD Cowen
    Dow Jones · 2026/10/14
  • Rating change
    TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Raises Target Price to $31
    Market Newswire · 2026/10/13
  • TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Raises Target Price to $36
    Market Newswire · 2026/11/5
  • Rating change
    BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Raises Target Price to $30
    Market Newswire · 2026/10/12
  • Rating change
    TD Cowen Maintains Buy on Schrodinger, Raises Price Target to $31
    Benzinga · 2026/10/14
  • Company notice
    Schrodinger | 4: Statement of changes in beneficial ownership of securities-Officer Davie Paul Jonathan
    SEC · 2026/11/13
  • Rating change
    UBS Maintains Neutral on Schrodinger, Raises Price Target to $21
    Benzinga · 2026/10/20
  • Rating change
    BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Raises Target Price to $35
    Market Newswire · 2026/11/5
  • Morgan Stanley Initiates Schrodinger(SDGR.US) With Hold Rating, Announces Target Price $29
    Market Newswire · 2026/11/5
  • Rating change
    Schrodinger Is Maintained at Neutral by UBS
    Dow Jones · 2026/10/20
  • Rating change
    KeyBanc Maintains Schrodinger(SDGR.US) With Buy Rating, Raises Target Price to $32
    Market Newswire · 2026/10/16
  • Rating change
    BMO Capital Maintains Outperform on Schrodinger, Raises Price Target to $30
    Benzinga · 2026/10/13
  • Company notice
    Schrodinger | 3: Initial statement of beneficial ownership of securities- Davie Paul Jonathan
    SEC · 2026/11/13
  • Company notice
    Schrodinger | 144: Notice of proposed sale of securities pursuant to Rule 144
    SEC · 2026/11/13
  • Earnings Preview: Schrodinger to Report Financial Results Post-market on November 04
    Market Newswire · 2026/10/30
  • Rating change
    UBS Initiates Schrodinger(SDGR.US) With Hold Rating, Announces Target Price $19
    Market Newswire · 2026/8/14
  • Company notice
    Schrodinger | 144: Notice of proposed sale of securities pursuant to Rule 144
    SEC · 2026/9/18
  • Rating change
    Analysts' Opinions Are Mixed on These Healthcare Stocks: Caribou Biosciences (CRBU), Bristol-Myers Squibb (BMY) and Schrodinger (SDGR)
    TipRanks · 2026/8/14
  • Rating change
    BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $24
    Market Newswire · 2026/8/18

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Schrodinger discussion 0 comments

Add a comment